Sensorion names Louis J. Arcudi III CFO, replaces Laurene Danon

Sensorion named Louis J. Arcudi III chief financial officer effective Oct. 7, 2026. Arcudi was CFO of Amolyt Pharma, acquired by AstraZeneca for up to USD 1.05 billion. Outgoing CFO Laurene Danon will remain as an adviser.